CD4 and hepatocellular carcinoma: The percentages of both CD8+ and double-negative (CD8-CD4-) T cells were lower in untreated HCC patients (p = 0.01; p = 0.0009), while the portion of CD4+ T cells was higher in untreated HCC (p = 0.0014) (Figure 3C) compared with healthy controls.